Related references
Note: Only part of the references are listed.Is Levodopa Response a Valid Indicator of Parkinson's Disease?
W. R. Wayne Martin et al.
MOVEMENT DISORDERS (2021)
Gastrointestinal dysfunction in Parkinson's disease
Michal Lubomski et al.
JOURNAL OF NEUROLOGY (2020)
Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson's Disease
Nai-Ching Chen et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Blood-Brain Barrier Leakage Is Increased in Parkinson's Disease
Sarah Al-Bachari et al.
FRONTIERS IN PHYSIOLOGY (2020)
Plasma alpha-synuclein levels in patients with Parkinson's disease: a systematic review and meta-analysis
Anastasia Bougea et al.
NEUROLOGICAL SCIENCES (2019)
Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?
David P. Breen et al.
MOVEMENT DISORDERS (2019)
Cognitive performance in mid-stage Parkinson's disease: functional connectivity under chronic antiparkinson treatment
Roxana Vancea et al.
BRAIN IMAGING AND BEHAVIOR (2019)
Pipeline to gene discovery - Analysing familial Parkinsonism in the Queensland Parkinson's Project
Steven R. Bentley et al.
PARKINSONISM & RELATED DISORDERS (2018)
A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease
Kirsten M. Scott et al.
FRONTIERS IN NEUROLOGY (2018)
Alpha-synuclein oligomers: a new hope
Nora Bengoa-Vergniory et al.
ACTA NEUROPATHOLOGICA (2017)
Association of genetic polymorphisms of claudin-1 with small vessel vascular dementia
Vivek Srinivasan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Imaging in Parkinson's disease
Gennaro Pagano et al.
CLINICAL MEDICINE (2016)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson's Disease after Elimination of Heterophilic Antibody Interference
Ryotaro Ishii et al.
PLOS ONE (2015)
Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease
Daniela Besong-Agbo et al.
NEUROLOGY (2013)
A deadly spread: cellular mechanisms of α-synuclein transfer
J. A. Steiner et al.
CELL DEATH AND DIFFERENTIATION (2011)
Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies?
Roberta Frigerio et al.
NEUROBIOLOGY OF AGING (2011)
Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations
L. M. Patrias et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Imaging Approaches to Parkinson Disease
David J. Brooks
JOURNAL OF NUCLEAR MEDICINE (2010)
Red blood cells are the major source of alpha-synuclein in blood
Robin Barbour et al.
NEURODEGENERATIVE DISEASES (2008)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease
PD Mehta et al.
ARCHIVES OF NEUROLOGY (2000)
Share Paper
